MwanzoUCB • EBR
add
UCB SA
Bei iliyotangulia
€ 181.55
Bei za siku
€ 183.40 - € 192.20
Bei za mwaka
€ 104.35 - € 198.95
Thamani ya kampuni katika soko
35.67B EUR
Wastani wa hisa zilizouzwa
elfu 220.32
Uwiano wa bei na mapato
35.11
Mgao wa faida
0.51%
Ubadilishanaji wa msingi
EBR
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (EUR) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 1.68B | 26.21% |
Matumizi ya uendeshaji wa biashara | 969.00M | 21.66% |
Mapato halisi | 428.50M | 2,578.12% |
Kiwango cha faida halisi | 25.50 | 2,025.00% |
Mapato kwa kila hisa | — | — |
EBITDA | 422.50M | 56.19% |
Asilimia ya kodi ya mapato | 6.54% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (EUR) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | — | — |
Jumla ya mali | — | — |
Jumla ya dhima | 7.32B | 11.49% |
Jumla ya hisa | — | — |
hisa zilizosalia | 190.04M | — |
Uwiano wa bei na thamani | 3.44 | — |
Faida inayotokana na mali | 3.76% | — |
Faida inayotokana mtaji | 5.00% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (EUR) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 428.50M | 2,578.12% |
Pesa kutokana na shughuli | — | — |
Pesa kutokana na uwekezaji | — | — |
Pesa kutokana na ufadhili | — | — |
Mabadiliko halisi ya pesa taslimu | 572.50M | 168.15% |
Mtiririko huru wa pesa | — | — |
Kuhusu
UCB is a multinational biopharmaceutical company headquartered in Brussels, Belgium. UCB is an international company with revenue of €4.178 billion in 2016 which focuses primarily on research and development, specifically involving medications centered on epilepsy, Parkinson's disease, and Crohn's disease. The company's efforts are focused on treatments for severe diseases treated by specialists, particularly in the fields of central nervous system disorders, inflammatory disorders, and oncology.
Every three years, the company presents the UCB Award under the patronage of the Queen Elisabeth Medical Foundation to promote neuroscience research. The winner of this award is selected by an independent scientific committee. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
18 Jan 1928
Tovuti
Wafanyakazi
9,215
